Althoff KN, Stewart CN, Humes E, et al. The shifting age distribution of people with HIV using antiretroviral therapy in the United States. AIDS. 2022;36:459–71.
Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15:810–8.
Guaraldi G, Malagoli A, Calcagno A, et al. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years. BMC Geriatr. 2018;18:99.
Brañas F, Galindo MJ, Torralba M, et al. Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: the FUNCFRAIL cohort study (GeSIDA 9817). PLoS One. 2022;17:e0266191.
Brañas F, Sánchez-Conde M, Carli F, et al. Sex differences in people aging with HIV. J Acquir Immune Defic Syndr. 2020;83:284–91.
Thames AD, Nunez R, Slavich GM, Irwin MR, Senturk D. Racial differences in health and cognition as a function of HIV among older adults. Clin Neuropsychol. 2022;36:367–87.
World Health Organization. World report on ageing and health. 2015. https://apps.who.int/iris/handle/10665/186463.
Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116:179–85.
Brañas F, Jiménez Z, Sánchez-Conde M, et al. Frailty and physical function in older HIV-infected adults. Age Ageing. 2017;46:522–6.
Yamada Y, Kobayashi T, Condo A, et al. Prevalence of frailty and Prefrailty in people with human immunodeficiency virus aged 50 or older: a systematic review and Meta-analysis. Open forum. Infect Dis. 2022;9:ofac129.
Verheij E, Kirk GD, Wit FW, et al. Frailty is associated with mortality and incident comorbidity among middle-aged human immunodeficiency virus (HIV)–positive and HIV-negative participants. J Infect Dis. 2020;222:919–28.
Piggott DA, Bandeen-Roche K, Mehta SH, et al. Frailty transitions, inflammation, and mortality among persons aging with HIV infection and injection drug use. AIDS. 2020;34:1217–25.
Falutz J, Brañas F, Erlandson KM. Frailty: the current challenge for aging people with HIV. Curr Opin HIV AIDS. 2021;16:133–40.
Greene M, Shi Y, Boscardin J, Sudore R, Gandhi M, Covinsky K. Geriatric conditions and healthcare utilisation in older adults living with HIV. Age Ageing. 2022;51:afac093.
Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355.
Jackson IL, Igwe CN, Effiong DE, Ukwe CV. Health-related quality of life of HIV positive patients with hypertension: is there an association with blood pressure control? High Blood Press Cardiovasc Prev. 2022;29:393–400.
Michel M, Labenz C, Anders M, et al. Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIV. Hepatol Commun. 2022;6:2011–21.
Yoshino Y, Wakabayashi Y, Kitazawa T. Relationship of sleep disorders with long-term complications and health-related quality of life in people with well-controlled human immunodeficiency virus. Medicine (Baltimore). 2022;101(11):e29070.
Chipanta D, Stöckl H, Toska E, et al. Facing the quality of life: physical illness, anxiety, and depression symptoms among people living with HIV in rural Zambia - a cross-sectional study. AIDS Care. 2022;34:957–65.
Sun W, Lu H, Huang F, Shiu C-S, Zhang L, Chen W-T. Longitudinal trajectory of the association between quality of life and depression among people living with HIV in China: a mixed effects model. AIDS Care. 2022;34:966–73.
Langebeek N, Kooij KW, Wit FW, et al. Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals. AIDS. 2017;31:1471–81.
Zeballos D, Lins L, Brites C. Frailty and its association with health related quality of life in older HIV patients, in Salvador. Brazil AIDS Res Hum Retroviruses. 2019;35:1074–81.
Sánchez-Conde M, Díaz-Álvarez J, Dronda F, Brañas F. Why are people with HIV considered "older adults" in their fifties? Eur Geriatr Med. 2019;10(2):183–8.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–57.
Nasreddine ZS, Phillips NA, BÃ©dirian V, et al. The Montreal cognitive assessment, MoCA: a Brief screening Tool for mild cognitive impairment: MOCA: a BRIEF SCREENING TOOL FOR MCI. J Am Geriatr Soc. 2005;53:695–9.
Damian AM, Jacobson SA, Hentz JG, et al. The Montreal cognitive assessment and the Mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31:126–31.
Burke WJ, Roccaforte WH, Wengel SP. The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4:173–8.
Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form Mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001;56:M366–72.
Justice AC, Modur SP, Tate JP, et al. Predictive accuracy of the veterans aging cohort study index for mortality with HIV infection: a north American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62:15.
Pelloquin R, Abdo M, MaWhinney S, Jankowski CM, Erlandson KM. Physical function and frailty tools in mortality prediction of middle-aged adults with HIV. JAIDS J Acquir Immune Defic Syndr. 2020;85:372–8.
Piggott DA, Varadhan R, Mehta SH, et al. Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol A Biol Sci Med Sci. 2015;70:1542–7.
Koroukian SM, Schiltz N, Warner DF, et al. Combinations of chronic conditions, functional limitations, and geriatric syndromes that predict health outcomes. J Gen Intern Med. 2016;31:630–7.
Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780–91.
Fried LP, Cohen AA, Xue Q-L, Walston J, Bandeen-Roche K, Varadhan R. The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nat Aging. 2021;1:36–46.
Liu JP. Aging mechanisms and intervention targets. Clin Exp Pharmacol Physiol. 2017;44:3–8.
Crocker TF, Brown L, Clegg A, et al. Quality of life is substantially worse for community-dwelling older people living with frailty: systematic review and meta-analysis. Qual Life Res. 2019;28:2041–56.
Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV – the new quality of life frontier. BMC Med. 2016;14(1):94.
UNAIDS. 90-90-90. An ambitious treatment target to help end the AIDS epidemic. Jt United Nations Program HIV/AIDS 2014. Available from: https://www.unaids.org/sites/default/files/media_a.
Waters L, Dunn D, Fink D, Gupta R, Hivitality AH, Steps P, et al. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022. Br HIV Assoc 2022. Available from: https://www.bhiva.org/file/6278cefb3f4c7/BHIVA-guidelines-on-antiretroviral-treatment-for-adults-living-with-HIV-1-2022-consultation-version.pdf.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf.
Ryom L, Cotter A, De Miguel R, et al. 2019 update of the European AIDS clinical society guidelines for treatment of people living with HIV version 10.0. HIV Med. 2020;21:617–24.
Guaraldi G, Marcotullio S, Maserati R, et al. The management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons. J Frailty Aging. 2019;8(1):10–16.
Kane RL, Shamliyan T, Talley K, Pacala J. The association between geriatric syndromes and survival. J Am Geriatr Soc. 2012;60:896–904.
Jiménez Z, Sánchez-Conde M, Brañas F. La infección por VIH como causa de envejecimiento acelerado y fragilidad. Rev Esp Geriatría Gerontol. 2018;53:105–10.
Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. 2014;69:833–42.
Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16:751–61.
Aung HL, Kootar S, Gates TM, Brew BJ, Cysique LA. How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection? Eur Geriatr med. 2019;10(2):227–38.
Naveed Z, Fox HS, Wichman CS, et al. Neurocognitive status and risk of mortality among people living with human immunodeficiency virus: an 18-year retrospective cohort study. Sci Rep. 2021;11:3738.
Banerjee N, McIntosh RC, Ironson G. Impaired neurocognitive performance and mortality in HIV: assessing the prognostic value of the HIV-dementia scale. AIDS Behav. 2019;23:3482–92.
Hosaka KRJ, Greene M, Premeaux TA, et al. Geriatric syndromes in older adults living with HIV and cognitive impairment. J Am Geriatr Soc. 2019;67:1913–6.
Charumbira MY, Berner K, Louw QA. Falls in people living with HIV: a scoping review. BMJ Open. 2020;10:e034872.